Cleveland BioLabs

About:

Cleveland BioLabs is a clinical-stage biotech developing a robust pipeline of drugs for multiple medical and defense applications.

Website: http://www.cbiolabs.com

Twitter/X: ClevelandBiolab

Top Investors: Hercules Capital, Norma Investment, David Davidovich

Description:

Cleveland BioLabs is a clinical-stage biotech developing a robust pipeline of drugs for multiple medical and defense applications, with a focus on oncology and tissue protection. The company pursues the research, development, and commercialization of proprietary products that have the potential to treat cancer, prevent, and treat acute radiation syndrome and counteract the toxic effects of radio and chemotherapies for oncology patients. Cleveland BioLabs was established in 2003 and is headquartered in Buffalo, New York.

Total Funding Amount:

$111M

Estimated Revenue Range:

Less than $1M

Headquarters Location:

Buffalo, New York, United States

Founded Date:

2003-01-01

Founders:

Andrei Gudkov, Michael Fonstein

Number of Employees:

51-100

Last Funding Date:

2021-02-19

IPO Status:

Delisted

Industries:

© 2025 bioDAO.ai